SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GENNEX LABORATORIES

BSE: 531739 28 Jun 2025
Healthcare
₹ 12.64
Gennex Laboratories Ltd specializes in Pharmaceuticals within the Healthcare sector.

GENNEX LABORATORIES - Share Price & Details

Market Cap
₹285.0
High /Low
29.0 / 11.2
Stock P/E
17.7
Book Value
₹8.21
Dividend Yield
0.0
ROCE
12.5
ROE
₹9.03
Face Value
1.0
PEG Ratio
0.32
EVEBITDA
₹9.45
Debt
27.1
CMP / FCF
-12.8
Debt to equity
₹0.15
NP Ann
18.1
High price all time
29.0
Piotroski score
₹5.0
Graham Number
11.4
No. Eq. Shares
22.7
Net CF
₹-5.41
Net profit
18.1
Price to book value
1.53
Interest Coverage
₹6.97
Low price all time
0.41
Industry PE
32.7
Reserves
₹164
Free Cash Flow
₹-19.6

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
GENNEX LABORATORIES LTD.NANANANA285.017.7
Nureca Limited337.4820.72317.52.07278
AMBALAL SARABHAI ENTERPRISES LNANANANA27327.2

Peer Comparison Chart


About GENNEX LABORATORIES

Gennex Laboratories Ltd, with Security Code 531739, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

What is the technical trend for Gennex Lab.?

(10 Jun 2025)
As of May 12, 2025, Gennex Lab's trend is mildly bearish, with daily moving averages and Bollinger Bands indicating bearishness,...
Read more →

GENNEX LABORATORIES TO DISCUSS RESULTS

(08 Jun 2025)
Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2025.
Read more →

Gennex Laboratories Reports Mixed Financial Results Amid Rising Sales in March 2025

(03 Jun 2025)
Gennex Laboratories has reported its financial results for the quarter ending March 2025, showcasing its highest quarterly net sales in five quarters at Rs...
Read more →

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

(23 May 2025)
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and...
Read more →

Gennex Laboratories Adjusts Evaluation Amid Strong Growth and Management Concerns

(13 May 2025)
Gennex Laboratories has recently experienced a change in its evaluation score, reflecting a shift in its technical outlook. The company has shown...
Read more →

Gennex Laboratories Faces Volatility Amidst Strong Operational Growth and Financial Concerns

(13 May 2025)
Gennex Laboratories has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has declined over...
Read more →